3001 90 20 to 3001 90 98 · Other
In addition to the glands and other organs mentioned in the HS Explanatory Note to heading 3001, (A), these subheadings include the hypophysis, the suprarenal capsules and the thyroid gland.
EU Combined Nomenclature · CN code · HS 3001.90
Heparin, glands and organotherapeutic goods
✓ Can be used in a customs declaration Data: EU Combined Nomenclature, in force from 1 January 2026 · checked on 24 October 2026
Importing into EU
Charges on top of the customs duty, and rules the goods must meet at the border.
The rate each member state applies to goods of this code, from the Commission’s Taxes in Europe Database. A reduced rate can cover only part of the goods under a code: check the national VAT law.
TEDB · 10 November 2026
| Country | Value | Share | Change |
|---|---|---|---|
| €208.1m | 37.7% | -30.7% | |
| €151.4m | 27.4% | +4.3% | |
| €130m | 23.5% | -7.4% | |
| €6.9m | 1.2% | -25.9% | |
| €6.8m | 1.2% | -13.2% | |
| €5.1m | 0.9% | +24.6% | |
| €4.8m | 0.9% | -22.4% | |
| €4.4m | 0.8% | +27.3% |
3001.90 Glands and other organs for organo-therapeutic uses, dried: other
Decisions of U.S. Customs and Border Protection (CROSS) and HMRC (Advance Tariff Rulings) on goods classified here. A ruling binds only its holder, but shows how the authorities classify similar goods. The descriptions are the authorities’ own, in English.
The tariff classification of nitinol tubing from Germany and bovine pericardium tissue from the Netherlands
The tariff classification of various tissue matrix, from the United States
Human tissue, The samples are of human tissue biological substances, being utilised for diagnostic testing and laboratory research as part of therapeutic clinical trials. It is important to note that human tissue samples are handled following stringent ethical and regulatory guidelines to maintain…
Human resected Tumour Material submerged in Phosphate Buffered Saline with Antibiotics. This is to be used as starting material in an autologous therapy.
The European Commission's explanatory notes on how to classify goods in these CN codes. They are not legally binding but customs authorities follow them; they complement the HS Explanatory Notes of the World Customs Organization.
In addition to the glands and other organs mentioned in the HS Explanatory Note to heading 3001, (A), these subheadings include the hypophysis, the suprarenal capsules and the thyroid gland.
See the HS Explanatory Note to heading 3001, (C).
General
The description of a product as a medicament in Union legislation (other than that relating specifically to classification in the Combined Nomenclature) or in the national legislation of the Member States, or in any pharmacopoeia, is not the deciding factor in so far as its classification in this chapter is concerned.
Additional note 1
1. Herbal medicinal preparations are preparations based on one or more active substances, produced by subjecting a plant or parts thereof to a process such as drying, crushing, extraction or purification.
Active substance means a chemically defined substance, a chemically defined group of substances (for example, alkaloids, polyphenols, anthocyanins) or a plant extract. These active substances must have medicinal properties for the prevention or the treatment of specific diseases, ailments or their symptoms.
2. Homeopathic medicinal preparations are prepared from products, substances or compositions called homeopathic stocks (mother tinctures). The degree of dilution must be indicated (for example, D6).
3. Vitamins or mineral preparations are preparations based on vitamins of heading 2936, on minerals including trace elements and mixtures thereof. They are used to treat or prevent specific diseases, ailments or their symptoms. Such preparations contain a much higher amount of vitamins or minerals, generally at least three times higher than the recommended daily allowance (RDA).
As regards the recommended daily allowance (RDA) for certain vitamins and minerals, see, for example, the table in the Annex XIII to Regulation (EU) No 1169/2011 of the European Parliament and of the Council of 25 October 2011 on the provision of food information to consumers (OJ L 304, 22.11.2011, p. 58) reproduced below:
| Vitamins and minerals | RDA |
| Vitamin A | 800 μg |
| Vitamin D | 5 μg |
| Vitamin E | 12 mg |
| Vitamin K | 75 μg |
| Vitamin C | 80 mg |
| Thiamin | 1,1 mg |
| Riboflavin | 1,4 mg |
| Niacin | 16 mg |
| Vitamin B6 | 1,4 mg |
| Folic acid | 200 μg |
| Vitamin B12 | 2,5 μg |
| Biotin | 50 μg |
| Pantothenic acid | 6 mg |
| Potassium | 2 000 mg |
| Chloride | 800 mg |
| Calcium | 800 mg |
| Phosphorus | 700 mg |
| Magnesium | 375 mg |
| Iron | 14 mg |
| Zinc | 10 mg |
| Copper | 1 mg |
| Manganese | 2 mg |
| Fluoride | 3,5 mg |
| Selenium | 55 μg |
| Chromium | 40 μg |
| Molybdenum | 50 μg |
| Iodine | 150 μg |
4. Recommended daily allowance (RDA) for adults with a weight of 70 kg, on essential amino acids, according to the joint WHO/FAO/UNU expert Consultation 2007:
| Essential Amino Acid | RDA (mg) |
| Histidine | 700 |
| Isoleucine | 1 400 |
| Leucine | 2 730 |
| Lysine | 2 100 |
| Methionine + Cysteine | 1 050 |
| Cysteine | 287 |
| Methionine | 728 |
| Phenylalanine + Tyrosine | 1 750 |
| Threonine | 1 050 |
| Tryptophan | 280 |
| Valine | 1 820 |
Recommended daily allowance (RDA) for adults with a weight of 70 kg, on essential fatty acids, according to the joint WHO/FAO/UNU expert Consultation 2007.
| Types of essential fatty acids | Name of essential fatty acid | RDA (g) |
| n-3 polyunsaturated fatty acids | linolenic acid (ALA) | 2 |
| long-chain n-3 polyunsaturated fatty acids | EPA plus DHA | 0,25 |
| n-6 polyunsaturated fatty acids | linoleic acid | 10 |
Heading 3004 does not cover, inter alia, food supplements or dietary preparations (see also note 1(a) to this chapter).
Explanatory Notes to the Combined Nomenclature of the European Union, Official Journal C (consolidated text and later amendments) · © European Union
The Combined Nomenclature of each year, as published in the Official Journal: description, third-country duty and supplementary unit.
| Year | Description | Third-country duty | Supplementary unit |
|---|---|---|---|
| 2026 | Heparin and its salts | Free | — |
| 2025 | unchanged | Free | — |
| 2024 | unchanged | Free | — |
| 2023 | unchanged | Free | — |
| 2022 | unchanged | Free | — |
| 2021 | unchanged | Free | — |
| 2020 | unchanged | Free | — |
| 2019 | Heparin and its salts | Free | — |
In the EU Combined Nomenclature, 3001 90 91 is one of 3 lines under subheading 3001.90, glands and other organs for organo-therapeutic uses, dried: other.
The third-country duty is free, and quantities are declared in —.
In the 12 months to August 2026, the EU imported heparin, glands and organotherapeutic goods (HS 3001.90) worth €552.5m (down 14% on the year before), at an average of €827.31 per kg; Singapore supplied 38%, followed by United States.
For the same subheading, the UK duty is free, the Türkiye duty is free, the US duty is free, the Canada duty is free, the Mexico duty is 0%–5%, the Brazil duty is 0%–7.2%, the Argentina duty is 0%–7.2%, the Peru duty is free, the New Zealand duty is free, the Japan duty is free, the Taiwan duty is free, the GCC duty is free, the Switzerland duty is free, the Norway duty is free, the North Macedonia duty is free and the Nigeria duty is free.
EU member states imported goods of subheading 3001.90 worth US$1.8bn in 2024; the largest supplier from outside the EU was Singapore, and the United Kingdom ranked 7th with US$5m.
The third-country duty in the EU Combined Nomenclature is free; the supplementary unit is —. Preferential rates for goods from agreement countries, anti-dumping duties and VAT are not included.
For subheading 3001.90 as a whole, the largest supplier from outside the EU in 2024 was Singapore (US$418m), followed by the United States.